State Street Corp Buys 95,613 Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

State Street Corp increased its stake in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 3.5% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,819,911 shares of the company’s stock after purchasing an additional 95,613 shares during the quarter. State Street Corp’s holdings in Acadia Healthcare were worth $178,811,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also modified their holdings of ACHC. Blue Trust Inc. lifted its stake in shares of Acadia Healthcare by 86.1% in the 2nd quarter. Blue Trust Inc. now owns 536 shares of the company’s stock valued at $36,000 after purchasing an additional 248 shares during the period. GAMMA Investing LLC lifted its stake in Acadia Healthcare by 57.1% in the third quarter. GAMMA Investing LLC now owns 663 shares of the company’s stock valued at $42,000 after buying an additional 241 shares during the period. Point72 Asia Singapore Pte. Ltd. bought a new position in Acadia Healthcare during the second quarter worth about $59,000. Covestor Ltd grew its position in shares of Acadia Healthcare by 834.4% during the 3rd quarter. Covestor Ltd now owns 1,140 shares of the company’s stock worth $72,000 after buying an additional 1,018 shares during the period. Finally, DekaBank Deutsche Girozentrale bought a new stake in shares of Acadia Healthcare in the 3rd quarter valued at about $86,000.

Analyst Ratings Changes

A number of brokerages recently issued reports on ACHC. Royal Bank of Canada decreased their price objective on shares of Acadia Healthcare from $94.00 to $64.00 and set an “outperform” rating for the company in a report on Monday, November 18th. KeyCorp assumed coverage on shares of Acadia Healthcare in a report on Friday, October 11th. They issued a “sector weight” rating for the company. Deutsche Bank Aktiengesellschaft raised Acadia Healthcare from a “hold” rating to a “buy” rating and raised their price objective for the stock from $45.00 to $75.00 in a research note on Thursday. StockNews.com cut Acadia Healthcare from a “hold” rating to a “sell” rating in a research note on Friday, November 22nd. Finally, Barclays dropped their price target on Acadia Healthcare from $76.00 to $43.00 and set an “overweight” rating on the stock in a research report on Friday, November 22nd. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and seven have given a buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $75.44.

Acadia Healthcare Stock Up 1.3 %

ACHC stock opened at $40.34 on Friday. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.07 and a quick ratio of 1.07. The stock has a market capitalization of $3.75 billion, a P/E ratio of 13.23, a P/E/G ratio of 1.82 and a beta of 1.29. Acadia Healthcare Company, Inc. has a fifty-two week low of $36.50 and a fifty-two week high of $87.77. The business has a 50-day moving average of $45.69 and a 200-day moving average of $61.98.

Acadia Healthcare (NASDAQ:ACHC) last released its quarterly earnings results on Wednesday, October 30th. The company reported $0.91 earnings per share for the quarter, topping analysts’ consensus estimates of $0.90 by $0.01. The firm had revenue of $815.60 million during the quarter, compared to the consensus estimate of $819.42 million. Acadia Healthcare had a return on equity of 11.12% and a net margin of 8.99%. The business’s revenue was up 8.7% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.91 EPS. On average, sell-side analysts anticipate that Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current fiscal year.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.